Skip to content
Research Article Open access CC BY 4.0

Clinical Factors Associated with Hypercoagulable and Prothrombotic Abnormalities in Patients with Acute Ischemic Stroke: A Prospective Observational Study

Waliul Haque, Samiha Afridin, Md. Belal Hossain, Souvik Halder, Murtaza M Joher, Fatima Fariha Anika, Faisal Al Mahmood, Rubaina Younus

Asian Journal of Medicine and Health · pp. 162–171 · Published 23 Sep 2026

10.9734/ajmah/2026/v24i101450

Abstract

Background:  Hypercoagulable and prothrombotic states may contribute to acute ischaemic stroke, particularly in younger patients and those with recurrent or otherwise unexplained thrombotic events. Aim: This study evaluated the frequency of selected hypercoagulable and prothrombotic laboratory abnormalities and identified clinical factors associated with their presence among patients with acute ischaemic stroke. Methods: This prospective observational study was conducted in the Department of Neurology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh, from January 2022 to December 2025. A total of 100 consecutive adults with imaging-confirmed acute ischaemic stroke were enrolled. The primary outcome was the presence of at least one predefined hypercoagulable or prothrombotic laboratory abnormality. Associations between clinical characteristics and the primary outcome were evaluated using univariable and multivariable logistic regression. Results: The mean age of the participants was 56.8 ± 11.4 years, and 62 (62.0%) were female. Hypertension was present in 69 (69.0%) patients, diabetes mellitus in 52 (52.0%), dyslipidaemia in 45 (45.0%), and current smoking in 37 (37.0%). Overall, 39 (39.0%) patients had at least one predefined hypercoagulable or prothrombotic laboratory abnormality. Antiphospholipid antibody abnormalities were identified in 18 (18.0%) patients and hyperhomocysteinaemia in 12 (12.0%). Patients with laboratory abnormalities were younger than those without abnormalities (53.7 ± 9.8 vs. 58.8 ± 11.2 years; p = 0.019), were more frequently female (74.4% vs. 54.1%; p = 0.041), and more frequently had previous venous thromboembolism (17.9% vs. 3.3%; p = 0.009). Severe neurological impairment, defined as NIHSS ≥15, was also more frequent among patients with abnormalities (41.0% vs. 19.7%; p = 0.019). In multivariable analysis, age <60 years (adjusted OR [aOR] 2.84, 95% CI 1.19–6.78; p = 0.022), female sex (aOR 2.18, 95% CI 1.01–4.72; p = 0.047), previous venous thromboembolism (aOR 3.91, 95% CI 1.29–11.82; p = 0.016), and NIHSS ≥15 (aOR 2.86, 95% CI 1.14–7.19; p = 0.024) were independently associated with the presence of a hypercoagulable or prothrombotic laboratory abnormality. Conclusion: Younger age, female sex, previous venous thromboembolism, and greater stroke severity were independently associated with these laboratory findings. These results support a clinically targeted rather than universal approach to thrombophilia evaluation in selected patients with ischaemic stroke. Because several thrombophilia assays may be affected by acute illness and anticoagulant therapy, abnormal findings obtained during the acute phase should be interpreted cautiously and confirmed after the acute event when clinically appropriate.

Acute ischaemic stroke hypercoagulability prothrombotic state venous thromboembolism stroke severity

References (25)

  1. 1 International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [DOI]
  2. 2 Mutation in blood coagulation factor V associated with resistance to activated protein C [DOI]
  3. 3 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association [DOI]
  4. 4 A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis [DOI]
  5. 5 EULAR recommendations for the management of antiphospholipid syndrome in adults [DOI]
  6. 6 Antiphospholipid syndrome [DOI]
  7. 7 Inherited Thrombophilia: Part 1 [DOI]
  8. 8 2023 ACR/EULAR antiphospholipid syndrome classification criteria [DOI]
  9. 9 Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies [DOI]
  10. 10 Guidance for the evaluation and treatment of hereditary and acquired thrombophilia [DOI]
  11. 11 Thrombophilia testing: A British Society for Haematology guideline [DOI]
  12. 12 Inherited Thrombophilia and the Risk of Arterial Ischemic Stroke: A Systematic Review and Meta‐Analysis [DOI]
  13. 13 Hematological disorders: a commonly unrecognized cause of acute stroke [DOI]
  14. 14 Guidelines on the investigation and management of antiphospholipid syndrome [DOI]
  15. 15 The role of homocysteine levels as a risk factor of ischemic stroke events: a systematic review and meta-analysis [DOI]
  16. 16 Preanalytical Issues in Hemostasis and Thrombosis Testing [DOI]
  17. 17 Thrombophilia Testing After Ischemic Stroke [DOI]
  18. 18 Stroke with polyvascular atherothrombotic disease [DOI]
  19. 19 Inherited Thrombophilia*: Part 2 [DOI]
  20. 20 Association of homocysteine level with risk of stroke: A dose–response meta-analysis of prospective cohort studies [DOI]
  21. 21 Clinical Impact of Thrombophilia Screening in Young Adults with Ischemic Stroke [DOI]
  22. 22 Thrombophilia testing in young patients with ischemic stroke [DOI]
  23. 23 Hyperhomocysteinemia and Ischemic Stroke: A Potential Dose-Response Association—A Systematic Review and Meta-analysis [DOI]
  24. 24 Homocysteine Levels in Acute Ischemic Stroke [DOI]
  25. 25 AN OVERVIEW ON HEREDITARY AND ACQUIRED HYPERCOAGULABILITY [DOI]

Cited by 0

No indexed citations yet.

Related research

Article metrics

Real usage data collected on this platform.

81

Page views

0

PDF downloads

52

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.